The overarching rationale was to create a multi-faceted epigenetic panel that captures different aspects of GBM biology: DNA repair and chemoresistance (MGMT), stress response and oncogenic signaling (NUPR1), tumor suppression (NDRG2), and developmental pathway activation (GLI1). The gene discussed is MGMT; the disease is glioblastoma.